Cabaletta Bio (CABA) Change in Acquisitions & Divestments (2020 - 2025)
Cabaletta Bio's quarterly Change in Acquisitions & Divestments came in at $50.0 million in Q4 2025, up 300.0% year-on-year from $12.5 million in Q4 2024, and up 300.0% quarter-over-quarter from $12.5 million in Q4 2024.
Cabaletta Bio has reported Change in Acquisitions & Divestments for 6 years, with the latest figure at $50.0 million in Q4 2025.
- For the quarter ending Q4 2025, Change in Acquisitions & Divestments rose 300.0% year-over-year to $50.0 million; the trailing twelve-month figure through Dec 2025 stood at $75.0 million (up 51.52% YoY), and the FY2025 full-year result was $50.0 million, up 1.01% from the prior year.
- Change in Acquisitions & Divestments for Q4 2025 stood at $50.0 million, up from $12.5 million in the prior quarter.
- The five-year high for Change in Acquisitions & Divestments was $50.0 million in Q4 2025, with the low at $1.0 million in Q4 2021.
- Average Change in Acquisitions & Divestments over 5 years is $17.7 million, with a median of $12.5 million recorded in 2024.
- Year-over-year, Change in Acquisitions & Divestments soared 986.96% in 2022 and slumped 66.67% in 2024.
- Tracing CABA's Change in Acquisitions & Divestments over 5 years: stood at $1.0 million in 2021, then soared by 2400.0% to $25.0 million in 2022, then soared by 50.0% to $37.5 million in 2023, then slumped by 66.67% to $12.5 million in 2024, then soared by 300.0% to $50.0 million in 2025.
- The last three Change in Acquisitions & Divestments figures came in at $50.0 million (Q4 2025), $12.5 million (Q4 2024), and $12.5 million (Q3 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Cabaletta Bio | 194.84 Mn | 61.24 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 50.00 Mn |
| Dec 31, 2025 | 50.00 Mn |
| Dec 31, 2024 | 12.50 Mn |
| Dec 31, 2024 | 12.50 Mn |
| Sep 30, 2024 | 12.50 Mn |
| Sep 30, 2024 | 12.50 Mn |
| Jun 30, 2024 | 24.50 Mn |
| Jun 30, 2024 | 24.50 Mn |
| Dec 31, 2023 | 37.50 Mn |
| Dec 31, 2023 | 37.50 Mn |
| Mar 31, 2023 | 25.00 Mn |
| Mar 31, 2023 | 25.00 Mn |
| Sep 30, 2022 | 25.00 Mn |
| Sep 30, 2022 | 25.00 Mn |
| Dec 31, 2021 | 1.00 Mn |
| Dec 31, 2021 | 1.00 Mn |
| Sep 30, 2021 | 2.30 Mn |
| Sep 30, 2021 | 2.30 Mn |
| Jun 30, 2021 | 1.42 Mn |
| Jun 30, 2021 | 1.42 Mn |
| Mar 31, 2021 | 2.45 Mn |
| Mar 31, 2021 | 2.45 Mn |
| Dec 31, 2020 | 2.12 Mn |
| Dec 31, 2020 | 2.12 Mn |